DPHARMA
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2017
Amended Announcements
Please refer to the earlier announcement reference number: FRA-25022018-00004
CCM DUOPHARMA BIOTECH BERHAD |
Financial Year End | 31 Dec 2017 |
Quarter | 4 Qtr |
Quarterly report for the financial period ended | 31 Dec 2017 |
The figures | have not been audited |
Remarks : |
Amendments have been made to columns 1 to 4 of item no. 6 of Part A2: Summary of Key Financial Information in respect of the Proposed/Declared dividend per share (Subunit). An amendment has also been made in respect of Note B10 (a) in relation to the comparative reference to the final dividend for 2016, on Page 4 of 5 of the Notes to Interim Financial Report for the Quarterly Report on Results for the Financial Year Ended 31 December 2017, as attached. As announced by the Company on 27 February 2018 prior to the announcement of the Quarterly Report for the financial period ended 31 December 2017, for the current financial year ended 31 December 2017, the Board of Directors recommends a final dividend of 6 sen per share (2016: a final dividend of 4 sen per share). The final dividend is subject to shareholders' approval at the Annual General Meeting (AGM) of the Company. The total dividend for the current financial year ended 31 December 2017 is 8.5 sen per share comprising of a final dividend of 6 sen and an interim dividend of 2.5 sen. The total dividend for preceding year corresponding period in respect of financial year ended 31 December 2016 was an Interim Dividend of 2.5 sen per share that was paid on 11 November 2016 and a final dividend of 4 sen per share that was paid on 23 June 2017. |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
31 Dec 2017
|
31 Dec 2016
|
31 Dec 2017
|
31 Dec 2016
|
||
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
1 | Revenue |
112,253
|
74,033
|
467,987
|
312,940
|
2 | Profit/(loss) before tax |
12,825
|
6,299
|
51,796
|
31,479
|
3 | Profit/(loss) for the period |
11,768
|
8,831
|
42,100
|
26,826
|
4 | Profit/(loss) attributable to ordinary equity holders of the parent |
11,870
|
8,428
|
42,492
|
27,115
|
5 | Basic earnings/(loss) per share (Subunit) |
4.22
|
3.41
|
15.09
|
9.62
|
6 | Proposed/Declared dividend per share (Subunit) |
6.00
|
4.00
|
8.50
|
6.50
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
1.7200
|
1.6300
|
Remarks : |
As announced by the Company on 27 February 2018 prior to the announcement of the Quarterly Report for the financial period ended 31 December 2017, for the current financial year ended 31 December 2017, the Board of Directors recommends a final dividend of 6 sen per share (2016: a final dividend of 4 sen per share). The final dividend is subject to shareholders' approval at the Annual General Meeting (AGM) of the Company. The total dividend for the current financial year ended 31 December 2017 is 8.5 sen per share comprising of a final dividend of 6 sen and an interim dividend of 2.5 sen. The total dividend for preceding year corresponding period in respect of financial year ended 31 December 2016 was an Interim Dividend of 2.5 sen per share that was paid on 11 November 2016 and a final dividend of 4 sen per share that was paid on 23 June 2017. |
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
Country | Base Unit | Subunit |
Malaysia | Ringgit | Sen |
United States | Dollar | Cent |
United Kingdom | Pound | Pence |
Announcement Info
Company Name | CCM DUOPHARMA BIOTECH BERHAD |
Stock Name | CCMDBIO |
Date Announced | 28 Feb 2018 |
Category | Financial Results |
Reference Number | FRA-28022018-00004 |